MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, August 4th 2020 - 17:49 UTC
Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said on Wednesday. Read full article
No comments for this story
Please log in or register (it’s free!) to comment.
Login with Facebook
Get our news on your inbox!